Bolt Biotherapeutics, Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-04

Reporting Person: LAPORTE KATHLEEN (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.41	2030-12-28	Common Stock (27857)		Direct

Footnotes

F1: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of December 29, 2020 (the "Vesting Commencement Date") for so long as the Reporting Person provides services to the Issuer, such that the total number of shares shall be fully vested on the third-year anniversary of the Vesting Commencement Date.